Skip to content
Home/Companies/Pharma/Apurano
Apurano

Apurano

Pharma·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Apurano?

Apurano is currently owned by Capmont through Capmont Private Equity (2006 vintage), since 2023.

Hand-verified · updated 2026-07-07

Capmont
Investor
Capmont
Capmont Private Equity · 2006 · Evergreen

Key facts

HQGermany
SectorPharma
StatusActive
Websiteapurano.de

More from Capmont Private Equity

Other portfolio companies in the same fund.

Dyneon
Active
IndustrialsGermany· 2026
Binetti Cablaggi
Active
IndustrialsItaly· 2025
Deutsche Fertighaus Holding
Active
ConsumerGermany· 2025
Liposphere
Liposphere
Active
MedTechGermany· 2025
Quad Europe
Active
Business ServicesGermany· 2025
Rockfin
Rockfin
Active
EnergyPoland· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Apurano

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Apurano?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Apurano.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue